Literature DB >> 9374983

The German health-care system.

D L Wahner-Roedler1, P Knuth, R H Juchems.   

Abstract

The German health-care system is characterized by a statutory health insurance based on the principle of social solidarity. Nonprofit sickness funds and regional associations of physicians are the central components of the German system. The historical development of the system for more than 100 years has been characterized by negotiations, rather than confrontation, among physicians, patients, and insurance carriers. With the increasing sophistication of modern medicine, medical expenditure is rising, and great demands are facing the health-care systems of the industrialized world. The hope is that the German system will be able to preserve the principle of solidarity and remain a one-tier health-care system rather than allow health care to be viewed as essentially a private consumption good, in which case availability and quality are allowed to vary with family income. As a means to achieve this goal, the autonomy of the sickness funds and regional associations of physicians will be increased substantially, and the governmental authority will be decreased. Strengthening of autonomy must be accompanied by incentives for self-responsibility and self-participation of Germany's citizens.

Entities:  

Mesh:

Year:  1997        PMID: 9374983     DOI: 10.4065/72.11.1061

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  2 in total

1.  Two types of health care systems and their influence on the introduction of perinatal care: an epidemiological twin model in Berlin from 1950 to 1990.

Authors:  B Arabin; E Raum; A Mohnhaupt; F W Schwartz
Journal:  Matern Child Health J       Date:  1999-06

2.  Exploring how Syrian women manage their health after migration to Germany: results of a qualitative study.

Authors:  Salma Kikhia; Ghaith Gharib; Alexandra Sauter; Natalia Caldeira Loss Vincens; Julika Loss
Journal:  BMC Womens Health       Date:  2021-02-02       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.